Valuation Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 16:00:02 2026-09-21 EDT			5-day change	1st Jan Change
377.33 ^USD	+0.24%		+2.38%	+24.54%

09-09	Bio-Rad Laboratories, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 03:45 PM
08-07	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,439	12,460	9,399	9,182	8,212	10,027	-	-
Change	-	-44.47%	-24.57%	-2.31%	-10.57%	22.1%	-	-
Enterprise Value (EV) ¹	22,439	11,868	8,992	8,730	7,874	9,278	9,062	8,920
Change	-	-47.11%	-24.24%	-2.91%	-9.8%	17.82%	-2.33%	-1.56%
P/E	5.38x	-	-14.8x	-5.03x	10.9x	45.4x	44.3x	44.7x
PBR	-	1.27x	1.05x	1.41x	1.11x	-	-	-
PEG	-	-	-	-0x	-0x	-0.6x	19.4x	-63.4x
Capitalization / Revenue	7.68x	4.45x	3.52x	3.58x	3.18x	3.9x	3.81x	3.74x
EV / Revenue	7.68x	4.24x	3.37x	3.4x	3.05x	3.61x	3.44x	3.33x
EV / EBITDA	33.1x	17.8x	16.8x	18.2x	17.4x	22.6x	20.8x	20x
EV / EBIT	39.3x	22.7x	23.7x	26.4x	25.3x	32.3x	28.5x	27.1x
EV / FCF	41.9x	127x	24x	-	-	30.2x	28.7x	26.9x
FCF Yield	2.39%	0.79%	4.17%	-	-	3.31%	3.49%	3.71%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	140.6	-	-21.82	-65.36	27.85	8.32	8.51	8.45
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,923	2,802	2,671	2,566	2,583	2,573	2,633	2,682
EBITDA ¹	677.5	667.9	535.9	479.5	453.2	410.3	435.1	446.5
EBIT ¹	571.2	524	378.9	331.3	311.6	287.5	318.4	328.8
Net income ¹	4,246	-3,628	-637.3	-1,844	759.9	224.8	229.7	228.3
Net Debt ¹	-	-592.5	-407.6	-452.1	-337.7	-749	-965.4	-1,107
Reference price ²	755.57	420.49	322.89	328.51	302.99	377.33	377.33	377.33
Nbr of stocks (in thousands)	29,918	29,824	29,145	27,997	26,975	26,738	-	-
Announcement Date	2/10/22	2/16/23	2/15/24	2/13/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIO-RAD LABORATORIES, INC.	45.24x	3.6x	22.56x	-.--%	10.01B
ABBOTT LABORATORIES	29.07x	4.01x	15.51x	2.51%	178B
MEDTRONIC PLC	19.49x	3.56x	12.71x	3.06%	118B
CENCORA, INC.	16.91x	0.2x	12.41x	0.77%	58.92B
BECTON, DICKINSON AND COMPANY	34.87x	3.38x	11.58x	2.17%	49.29B
HOYA CORPORATION	27.56x	6.78x	17.54x	1.45%	48.17B
DEXCOM, INC.	35.82x	6.3x	19.78x	-.--%	33.72B
MEDLINE INC.	40.85x	1.21x	11.23x	0.23%	27.76B
WEST PHARMACEUTICAL SERVICES, INC.	42.25x	7.41x	26.57x	0.25%	25.5B
SARTORIUS STEDIM BIOTECH	50.52x	6.81x	21.88x	0.42%	22.1B
Average	34.26x	4.33x	17.18x	1.09%	57.09B
Weighted average by Cap.	28.88x	3.96x	15.35x	1.84%